New Leaf Venture Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-576,975
| Closed | -$9.08M | – | 11 |
|
|
2024
Q1 | $9.08M | Hold |
576,975
| – | – | 7.94% | 3 |
|
|
2023
Q4 | $9.31M | Sell |
576,975
-632,596
| -52% | -$8.07M | 7.5% | 4 |
|
|
2023
Q3 | $15.4M | Hold |
1,209,571
| – | – | 19.76% | 2 |
|
|
2023
Q2 | $17M | Hold |
1,209,571
| – | – | 14.63% | 4 |
|
|
2023
Q1 | $18.7M | Hold |
1,209,571
| – | – | 15.44% | 3 |
|
|
2022
Q4 | $19.8M | Hold |
1,209,571
| – | – | 14.35% | 3 |
|
|
2022
Q3 | $22.4M | Hold |
1,209,571
| – | – | 13.28% | 3 |
|
|
2022
Q2 | $15.9M | Hold |
1,209,571
| – | – | 10.3% | 3 |
|
|
2022
Q1 | $11.2M | Hold |
1,209,571
| – | – | 5.53% | 5 |
|
|
2021
Q4 | $11.8M | Hold |
1,209,571
| – | – | 4.28% | 7 |
|
|
2021
Q3 | $41.1M | Hold |
1,209,571
| – | – | 11.86% | 2 |
|
|
2021
Q2 | $33.1M | Hold |
1,209,571
| – | – | 8.51% | 4 |
|
|
2021
Q1 | $54.2M | Hold |
1,209,571
| – | – | 12.62% | 3 |
|
|
2020
Q4 | $69M | Hold |
1,209,571
| – | – | 15.95% | 2 |
|
|
2020
Q3 | $62.1M | Hold |
1,209,571
| – | – | 25% | 1 |
|
|
2020
Q2 | $72.2M | Sell |
1,209,571
-877,152
| -42% | -$46.9M | 20.73% | 2 |
|
|
2020
Q1 | $85.9M | Hold |
2,086,723
| – | – | 25.7% | 2 |
|
|
2019
Q4 | $130M | Sell |
2,086,723
-988,102
| -32% | -$47M | 28.22% | 1 |
|
|
2019
Q3 | $104M | Sell |
3,074,825
-1,029,315
| -25% | -$30.5M | 31.57% | 1 |
|
|
2019
Q2 | $92.5M | Hold |
4,104,140
| – | – | 24.81% | 1 |
|
|
2019
Q1 | $95.3M | Hold |
4,104,140
| – | – | 26.1% | 1 |
|
|
2018
Q4 | $86.1M | Hold |
4,104,140
| – | – | 23.65% | 1 |
|
|
2018
Q3 | $159M | Hold |
4,104,140
| – | – | 28.92% | 1 |
|
|
2018
Q2 | $161M | Hold |
4,104,140
| – | – | 38.98% | 1 |
|
|
2018
Q1 | $82.2M | Hold |
4,104,140
| – | – | 44.41% | 1 |
|
|
2017
Q4 | $93M | Hold |
4,104,140
| – | – | 43.52% | 1 |
|
|
2017
Q3 | $77.9M | Buy |
+4,104,140
| New | +$75.2M | 36.17% | 1 |
|
Other funds holding DCPH
New Leaf Venture Partners's DCPH Position: Q2 2024 in Review
New Leaf Venture Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 576,975 shares — an estimated $9.08M sold.
New Leaf Venture Partners first reported a position in DCPH in Q3 2017 and held it in 27 quarters. The position peaked at $161M in Q2 2018. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- New Leaf Venture Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- New Leaf Venture Partners sold 576,975 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $9.08M.
- New Leaf Venture Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 27 quarters.
- New Leaf Venture Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $161M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on New Leaf Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.